rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-5-1
|
pubmed:abstractText |
It has not been fully evaluated whether both HER2 gene copy number and HER2 protein expression are related to the outcome of chemoradiotherapy in patients with locally advanced non-small cell lung cancer (LA-NSCLC). The aim of this study was to evaluate their relationships.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1556-1380
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
477-82
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18448999-Adult,
pubmed-meshheading:18448999-Aged,
pubmed-meshheading:18448999-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18448999-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18448999-Chromosomes, Human, Pair 17,
pubmed-meshheading:18448999-Cisplatin,
pubmed-meshheading:18448999-Data Interpretation, Statistical,
pubmed-meshheading:18448999-Female,
pubmed-meshheading:18448999-Gene Dosage,
pubmed-meshheading:18448999-Genes, erbB-2,
pubmed-meshheading:18448999-Humans,
pubmed-meshheading:18448999-In Situ Hybridization, Fluorescence,
pubmed-meshheading:18448999-Lung Neoplasms,
pubmed-meshheading:18448999-Male,
pubmed-meshheading:18448999-Middle Aged,
pubmed-meshheading:18448999-Peptide Fragments,
pubmed-meshheading:18448999-Prognosis,
pubmed-meshheading:18448999-Receptor, erbB-2,
pubmed-meshheading:18448999-Survival Rate,
pubmed-meshheading:18448999-Taxoids,
pubmed-meshheading:18448999-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer.
|
pubmed:affiliation |
Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
|
pubmed:publicationType |
Journal Article
|